Decibel Cannabis Company Inc. (TSXV: DB)
Health Care · Pharmaceuticals · CA
CA$1.72
-3.37% today · -18.1% 1Y
Decibel Cannabis Company Inc. (TSXV: DB) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $46.40M and employs 171 people.
Over the last twelve months the share price has lost 18.1%, trading between 1.35 and 2.17.
Tweenvest scores Decibel Cannabis Company Inc. across four factors: quality 51/100, value 73/100, growth 100/100. Its strongest factor is growth.
DB price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $46.40M
- Revenue (TTM)
- $89.49M
- P/E
- —
- EPS
- -0.09
- Dividend yield
- —
- Beta (5Y)
- 0.48
- 52-week high
- CA$2.17
- 52-week low
- CA$1.35
- Avg volume (3M)
- —
- Shares outstanding
- 38.47M
- Employees
- 171
- Next earnings
- —
About Decibel Cannabis Company Inc.
Decibel Cannabis Company Inc. operates within Canada's cannabis industry, overseeing the entire spectrum from growing and processing to manufacturing and selling its diverse product line. It serves other licensed Canadian producers by supplying cannabis flower, pre-rolled offerings, and bulk biomass. Additionally, the company excels in the intricate processes of extracting, refining, and producing a variety of cannabis derivative goods, such as vape cartridges, edibles, and concentrated extracts. Consumers can find its products under proprietary labels including Qwest, Qwest Reserve, Blendcraft by Qwest, and General Admission. Decibel Cannabis Company Inc. has its corporate headquarters situated in Calgary, Canada.
- ISIN
- CA2434371001
- Listed since
- Mar 4, 2019
- Exchange
- TSX Venture Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| PharmGen Science, Inc.KOSE: A004720 | $47.85M | ₩2,850.00 | +0.88% |
| Haleos Labs LimitedNSEI: HALEOSLABS | $46.79M | Rs1,490.00 | -0.79% |
| Trident Lifeline LimitedBSE: 543616 | $46.64M | Rs376.35 | -7.69% |
| Orexo AB (publ)OM: ORX | $46.63M | Skr7.00 | -47.76% |
| Nasus Pharma Ltd.NYSEAM: NSRX | $45.92M | $3.78 | -3.70% |
| Impact BioMedical Inc.NYSEAM: IBO | $45.45M | $4.66 | -12.41% |
| LeonaBio, Inc.NasdaqCM: LONA | $45.41M | $5.67 | +17.63% |
| Filana Therapeutics, Inc.NasdaqCM: FLNA | $44.97M | $0.81 | -13.21% |
Figures last refreshed Oct 4, 2026.